ARCHIVE

• August 25, 2003

• PRESS SEMINAR
  August 25, 2003

• 31 Mono-drugs, 7 Combination Drugs Designated for Quality Reevaluation
  August 25, 2003

• Yamanouchi to Beef Up Marketing to Gain 6% Share: President Takenaka
  August 25, 2003

• DIAGNOSTIC NEWS IN BRIEF
  August 25, 2003

• 31 Ingredients Designated for 26th Quality Reevaluation
  August 25, 2003

• Shionogi Places Top Priority on Proper Use in Marketing Opioids for Cancer Pain
  August 25, 2003

• AnGes MG Granted Patent Rights on HGF Gene Therapy
  August 11, 2003

• Sosei Raises \1.6 Billion to Finance Development
  August 11, 2003

• Part of Revised PAL Goes into Effect on July 30
  August 11, 2003

• Financial Results in 1st Quarter
  August 11, 2003

• National Medical Costs Rose 3.2% in FY2001: Korosho
  August 11, 2003

• REGULATORY NEWS IN BRIEF
  August 11, 2003

• Natural Increases in Social Insurance Spending to Become \687 Bil.
  August 11, 2003

• METI to Prepare GL for Disclosure of Information on Patents
  August 11, 2003

• Maruko Enters Itochu Group
  August 11, 2003

• Social Security Council Committee to Discuss Basic Policy for Healthcare Reform
  August 11, 2003

• JT Licenses 3 Anti-HIV Drugs from Gilead
  August 11, 2003

• Chuikyo Discusses Off-label Use Not Covered by Insurance
  August 11, 2003

• Torii to Seek Outside Products to Shore up Sales
  August 11, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 581
• 582
• 583
• 584
• 585
• 586
• 587
• 588
• 589
• …
• Next ›
• 最終 »